---
figid: PMC9099194__WJG-28-1781-g006
pmcid: PMC9099194
image_filename: WJG-28-1781-g006.jpg
figure_link: /pmc/articles/PMC9099194/figure/F6/
number: Figure 6
figure_title: ''
caption: 'Prognostic value of the combination of forkhead Box q1 and heparin binding
  epidermal growth factor. A: Representative immunohistochemical images of forkhead
  Box q1 (FOXQ1) and heparin binding epidermal growth factor (HB-EGF) positive coexpression
  and negative coexpression in human colorectal cancer tissues and adjacent nontumorous
  tissues. Scale bars represent 200 Î¼m; B: Kaplan-Meier survival analysis was used
  to evaluate the overall survival rate in the following patients: FOXQ1-positive
  and FOXQ1-negative patients; HB-EGF-positive and HB-EGF-negative patients; and FOXQ1-positive
  and FOXQ1-negative coexpressing HB-EGF-positive and HBEGF-negative patients. aP
  < 0.05; bP < 0.01; cP < 0.001 indicate a significant difference between the indicated
  groups (log-rank test). FOXQ1: Forkhead Box q1; HB-EGF: Heparin binding epidermal
  growth factor.'
article_title: Forkhead Box q1 promotes invasion and metastasis in colorectal cancer
  by activating the epidermal growth factor receptor pathway.
citation: Jin-Jin Zhang, et al. World J Gastroenterol. 2022 May 7;28(17):1781-1797.
year: '2022'

doi: 10.3748/wjg.v28.i17.1781
journal_title: World Journal of Gastroenterology
journal_nlm_ta: World J Gastroenterol
publisher_name: Baishideng Publishing Group Inc

keywords:
- Colorectal cancer
- Forkhead Box Q1
- Heparin binding epidermal growth factor
- Epidermal growth factor receptor pathway
- Migration
- Invasion

---
